Organon & Co. Earnings

Organon & Co.’s revenue fell -6.72% since last year same period to $1513Mn in the Q1 2025. On a quarterly growth basis, Organon & Co. has generated -4.96% fall in its revenue since last 3-months.

Organon & Co.’s net profit fell -56.72% since last year same period to $87Mn in the Q1 2025. On a quarterly growth basis, Organon & Co. has generated -20.18% fall in its net profits since last 3-months.

Organon & Co.’s net profit margin fell -53.6% since last year same period to 5.75% in the Q1 2025. On a quarterly growth basis, Organon & Co. has generated -16.02% fall in its net profit margins since last 3-months.

Organon & Co.’s price-to-earnings ratio after this Q1 2025 earnings stands at 3.52.

Organon & Co.’s earning per share (EPS) estimates for the current quarter stand at 0.94 - a -7.31% fall from last quarter’s estimates.

Organon & Co.’s earning per share (EPS) estimates for the current year stand at 0.94.

Organon & Co.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Organon & Co. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Organon & Co. declared 0.02 dividend per share during the earnings announcement for Q2 2025.